Search clinical trials for: Azelaic Acid (Finacea Foam, BAY39-6251)

Total 26 results

LEO Pharma
Bayer

Completed

A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea

Rosacea

United States
LEO Pharma
Bayer

Completed

Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea

Papulopustular Rosacea

United States
LEO Pharma
Bayer

Completed

Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne

Acne Vulgaris

United States
Padagis LLC
DPT Laboratories, Ltd.

Completed

Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face

Rosacea

United States
Clinical Research Center of the Carolinas
Bayer

Completed

Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea

Rosacea, Papulopustular

United States
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea

Rosacea

United States
LEO Pharma
Bayer

Completed

Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea

Papulopustular Rosacea

United States
Actavis Inc.

Completed

A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea

Rosacea

United States
Actavis Inc.

Completed

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

Rosacea

United States
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel

Rosacea
LEO Pharma
Bayer

Completed

Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea

Papulopustular Rosacea

United States
Wake Forest University Health Sciences

Not yet recruiting

Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA) ((CCCA))

Central Centrifugal Cicatricial Alopecia

United States
LEO Pharma
Bayer

Completed

Preferences & Treatment Satisfaction Drivers in Rosacea Patients

Rosacea

United States
LEO Pharma
Bayer

Completed

Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea

Papulopustular Rosacea

United States
LEO Pharma
Bayer

Completed

Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation

Healthy

United States
Derm Research, PLLC
Bayer

Completed

Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)

Acne Vulgaris | Post Inflammatory Hyperpigmentation

United States
Wake Forest University Health Sciences
Bayer

Completed

Combination Gel and Vascular ND in Mild to Moderate Rosacea

Rosacea

United States
Wake Forest University

Completed

Azelaic Acid on Demodex Counts in Rosacea

Rosacea

United States
LEO Pharma
Bayer

Completed

21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation

Healthy

United States
LEO Pharma
Bayer

Completed

Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea

Papulopustular Rosacea

United States
Galderma R&D

Completed

Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy Skin

Skin Manifestations

United States
Galderma R&D

Completed

Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin

Skin Manifestations

United States
Callender Center for Clinical Research

Unknown

Azelaic Acid Versus Hydroquinone in Melasma

Melanosis

United States
Dermatology Specialists Research

Completed

Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea

Rosacea

United States
Derm Research, PLLC
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Completed

Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study

Acne Rosacea

United States
Galderma R&D

Completed

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

Erythema | Rosacea

United States

3

Subscribe